NEW YORK(GenomeWeb) – Natera plans to offer 6.25 million shares of its stock in its initial public offering, raising up to $103.3 million in net proceeds, it said in a document filed with the US Securities and Exchange Commission today. 

In an amended Form S-1, the San Carlos, California-based non-invasive prenatal testing firm said it plans to price its shares at between $15 and $17. At the midpoint price of $16, net proceeds from the offering are anticipated to be $89.3 million, or $103.3 million if the underwriters exercise their overallotment option in full.